220 related articles for article (PubMed ID: 34157091)
1. Splicing factor mutations in hematologic malignancies.
Chen S; Benbarche S; Abdel-Wahab O
Blood; 2021 Aug; 138(8):599-612. PubMed ID: 34157091
[TBL] [Abstract][Full Text] [Related]
2. RNA splicing factors in normal hematopoiesis and hematologic malignancies: novel therapeutic targets and strategies.
Li Z; He Z; Wang J; Kong G
J Leukoc Biol; 2023 Feb; 113(2):149-163. PubMed ID: 36822179
[TBL] [Abstract][Full Text] [Related]
3. Splicing Factor Mutations in Cancer.
Bejar R
Adv Exp Med Biol; 2016; 907():215-28. PubMed ID: 27256388
[TBL] [Abstract][Full Text] [Related]
4. Splicing factor gene mutations in hematologic malignancies.
Saez B; Walter MJ; Graubert TA
Blood; 2017 Mar; 129(10):1260-1269. PubMed ID: 27940478
[TBL] [Abstract][Full Text] [Related]
5. RNA-binding proteins in hematopoiesis and hematological malignancy.
Hodson DJ; Screen M; Turner M
Blood; 2019 May; 133(22):2365-2373. PubMed ID: 30967369
[TBL] [Abstract][Full Text] [Related]
6. Splicing regulation in hematopoiesis.
Chen S; Abdel-Wahab O
Curr Opin Hematol; 2021 Jul; 28(4):277-283. PubMed ID: 33973558
[TBL] [Abstract][Full Text] [Related]
7. [RNA splicing dysregulation in hematological malignancies].
Yoshida M; Yamauchi H; Sakumoto M; Yoshimi A
Rinsho Ketsueki; 2023; 64(7):646-653. PubMed ID: 37544725
[TBL] [Abstract][Full Text] [Related]
8. [Hematological malignancies driven by aberrant splicing].
Zang W; Saika W; Aoyama Y; Inoue D
Rinsho Ketsueki; 2023; 64(9):875-883. PubMed ID: 37793861
[TBL] [Abstract][Full Text] [Related]
9. Targeting Splicing in the Treatment of Myelodysplastic Syndromes and Other Myeloid Neoplasms.
Brierley CK; Steensma DP
Curr Hematol Malig Rep; 2016 Dec; 11(6):408-415. PubMed ID: 27492253
[TBL] [Abstract][Full Text] [Related]
10. Splicing factor mutant myelodysplastic syndromes: Recent advances.
Pellagatti A; Boultwood J
Adv Biol Regul; 2020 Jan; 75():100655. PubMed ID: 31558432
[TBL] [Abstract][Full Text] [Related]
11. ASXL1 mutation in clonal hematopoiesis.
Fujino T; Kitamura T
Exp Hematol; 2020 Mar; 83():74-84. PubMed ID: 31945396
[TBL] [Abstract][Full Text] [Related]
12. Splicing factor deficits render hematopoietic stem and progenitor cells sensitive to STAT3 inhibition.
Potts KS; Cameron RC; Metidji A; Ghazale N; Wallace L; Leal-Cervantes AI; Palumbo R; Barajas JM; Gupta V; Aluri S; Pradhan K; Myers JA; McKinstry M; Bai X; Choudhary GS; Shastri A; Verma A; Obeng EA; Bowman TV
Cell Rep; 2022 Dec; 41(11):111825. PubMed ID: 36516770
[TBL] [Abstract][Full Text] [Related]
13. Modeling human RNA spliceosome mutations in the mouse: not all mice were created equal.
Xu JJ; Smeets MF; Tan SY; Wall M; Purton LE; Walkley CR
Exp Hematol; 2019 Feb; 70():10-23. PubMed ID: 30408513
[TBL] [Abstract][Full Text] [Related]
14. Single-cell genomics reveals the genetic and molecular bases for escape from mutational epistasis in myeloid neoplasms.
Taylor J; Mi X; North K; Binder M; Penson A; Lasho T; Knorr K; Haddadin M; Liu B; Pangallo J; Benbarche S; Wiseman D; Tefferi A; Halene S; Liang Y; Patnaik MM; Bradley RK; Abdel-Wahab O
Blood; 2020 Sep; 136(13):1477-1486. PubMed ID: 32640014
[TBL] [Abstract][Full Text] [Related]
15. Mutations of RNA splicing factors in hematological malignancies.
Shukla GC; Singh J
Cancer Lett; 2017 Nov; 409():1-8. PubMed ID: 28888996
[TBL] [Abstract][Full Text] [Related]
16. Acquired mutations that affect pre-mRNA splicing in hematologic malignancies and solid tumors.
Scott LM; Rebel VI
J Natl Cancer Inst; 2013 Oct; 105(20):1540-9. PubMed ID: 24052622
[TBL] [Abstract][Full Text] [Related]
17. RNA modifications in hematopoietic malignancies: a new research frontier.
Qing Y; Su R; Chen J
Blood; 2021 Aug; 138(8):637-648. PubMed ID: 34157073
[TBL] [Abstract][Full Text] [Related]
18. SRSF2 mutations drive oncogenesis by activating a global program of aberrant alternative splicing in hematopoietic cells.
Liang Y; Tebaldi T; Rejeski K; Joshi P; Stefani G; Taylor A; Song Y; Vasic R; Maziarz J; Balasubramanian K; Ardasheva A; Ding A; Quattrone A; Halene S
Leukemia; 2018 Dec; 32(12):2659-2671. PubMed ID: 29858584
[TBL] [Abstract][Full Text] [Related]
19. Molecular Pathways: Understanding and Targeting Mutant Spliceosomal Proteins.
Yoshimi A; Abdel-Wahab O
Clin Cancer Res; 2017 Jan; 23(2):336-341. PubMed ID: 27836865
[TBL] [Abstract][Full Text] [Related]
20. Defects in spliceosomal machinery: a new pathway of leukaemogenesis.
Maciejewski JP; Padgett RA
Br J Haematol; 2012 Jul; 158(2):165-173. PubMed ID: 22594801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
